Last reviewed · How we verify
application of the topic gel
A topical gel formulation designed for local application to affected skin or mucosal areas.
At a glance
| Generic name | application of the topic gel |
|---|---|
| Sponsor | Igefarma Laboratorios S.A. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Without specific active pharmaceutical ingredient information, the exact mechanism cannot be determined. Topic gels are typically formulations that deliver therapeutic agents directly to the site of application, allowing for localized treatment while minimizing systemic exposure. The specific mechanism would depend on the active ingredient(s) contained within the gel matrix.
Approved indications
Common side effects
Key clinical trials
- To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment. (NA)
- Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder (PHASE2)
- Dentine Hypersensitivity Treated With Laser and Fluoride. (NA)
- A Prospective, Randomized, Clinical Study on the Effects of CPP-ACP-paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding. (NA)
- Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients (PHASE2)
- Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures (PHASE4)
- Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas (PHASE2)
- Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- application of the topic gel CI brief — competitive landscape report
- application of the topic gel updates RSS · CI watch RSS
- Igefarma Laboratorios S.A. portfolio CI